13 September 2022 - - US-based scientific instruments, regeants and consumables, and software services provider Thermo Fisher Scientific (NYSE: TMO) has certified the Applied Biosystems QuantStudio 7 Pro Dx Real-Time PCR System to meet new In Vitro Medical Devices Regulation requirements, the company said.

The updated system now includes new, complementary Applied Biosystems Diomni Software ecosystem to empower clinical labs and test developers to leverage flexible PCR testing onsite.

Designed for maximum productivity and fast ramp-up, the QuantStudio 7 Pro Dx Real-Time PCR System enables users to transition from development to validation on a single system.

The expandable, automated platform comes with interchangeable 96-well and 384-well blocks and also includes remote desktop and touchscreen controls, facial authentication, voice command and smart tech support to increase user productivity.

Whether performing a routine test or developing a new assay, the integrated, IVDR-compliant Applied Biosystems Diomni Software ecosystem is designed to streamline the entire workflow with a plug-and-play design and simplified set-up to enhance efficiency and minimize user error.

The centralized set-up allows connection to multiple real-time PCR instruments and secure data sharing across a user network.

The QuantStudio 7 Pro Dx Real-Time PCR System is available in all regions that recognize CE-IVD certification and is also listed with the US Food and Drug Administration as a class II medical device.